Hui Han

620 total citations
25 papers, 310 citations indexed

About

Hui Han is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Hui Han has authored 25 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Hui Han's work include Boron Compounds in Chemistry (5 papers), Cancer-related molecular mechanisms research (5 papers) and Organoboron and organosilicon chemistry (4 papers). Hui Han is often cited by papers focused on Boron Compounds in Chemistry (5 papers), Cancer-related molecular mechanisms research (5 papers) and Organoboron and organosilicon chemistry (4 papers). Hui Han collaborates with scholars based in China, United States and Australia. Hui Han's co-authors include Fangli Cao, Xi-sheng Leng, Pengcheng Chen, Yufeng Cheng, Jirun Peng, Fang Zhang, Lei Gong, Juan Zhou, Huimin Li and Meirong Liu and has published in prestigious journals such as Oncogene, Chemical Communications and Scientific Reports.

In The Last Decade

Hui Han

25 papers receiving 301 citations

Peers

Hui Han
Yukari Ishiguro Japan
Amr S. Saad Egypt
Leo Y. Luo United States
Yaqi Song China
Anrong Mao China
Zhe-Sheng Wen China
Yuping Zhu China
Huijuan Feng China
Yukari Ishiguro Japan
Hui Han
Citations per year, relative to Hui Han Hui Han (= 1×) peers Yukari Ishiguro

Countries citing papers authored by Hui Han

Since Specialization
Citations

This map shows the geographic impact of Hui Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Han more than expected).

Fields of papers citing papers by Hui Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Han. The network helps show where Hui Han may publish in the future.

Co-authorship network of co-authors of Hui Han

This figure shows the co-authorship network connecting the top 25 collaborators of Hui Han. A scholar is included among the top collaborators of Hui Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Han. Hui Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Lijuan, Minyan Chen, Lili Chen, et al.. (2025). Timing of surgery and 1‐year postoperative outcomes in patients with breast cancer and preoperative COVID‐19 history: A matched, longitudinal, ambidirectional cohort study. International Journal of Cancer. 157(6). 1183–1196. 1 indexed citations
2.
Jing, Yi, Xinghua Wang, Hui Han, et al.. (2025). Facile synthesis of the dodecahydridododecaborate (B12H122−) from borane Lewis base adducts. Science China Chemistry. 68(4). 1355–1361. 3 indexed citations
3.
Goto, Keiko, Benjamin Solomon, K. Park, et al.. (2023). LBA4 Randomized phase III study of first-line selpercatinib versus chemotherapy and pembrolizumab in RET fusion-positive NSCLC. Annals of Oncology. 34. S1303–S1303. 4 indexed citations
4.
Jing, Yi, Xinghua Wang, Hui Han, et al.. (2023). Selective synthesis of the B11H14− and B12H122− borane derivatives and the general mechanisms of the B-H bond condensation. Science China Chemistry. 67(3). 876–881. 15 indexed citations
5.
Liu, Jiameng, et al.. (2022). Breast conserving therapy for central breast cancer in the United States. BMC Surgery. 22(1). 31–31. 9 indexed citations
6.
Zhang, Juan, Ying Ma, Wenming Yang, et al.. (2021). Differentially expressed lncRNAs in liver tissues of TX mice with hepatolenticular degeneration. Scientific Reports. 11(1). 1377–1377. 7 indexed citations
7.
8.
Zhang, Zhenxing, et al.. (2020). LncRNA PLAC2 upregulates miR-663 to downregulate TGF-β1 and suppress bladder cancer cell migration and invasion. BMC Urology. 20(1). 94–94. 14 indexed citations
9.
Zhang, Dongda, Ning Jin, Weili Sun, et al.. (2020). Correction: Phosphoglycerate mutase 1 promotes cancer cell migration independent of its metabolic activity. Oncogene. 39(11). 2451–2452. 2 indexed citations
10.
Han, Hui, Huimin Li, & Juan Zhou. (2020). Long non-coding RNA MIR503HG inhibits the proliferation, migration and invasion of colon cancer cells via miR-107/Par4 axis. Experimental Cell Research. 395(2). 112205–112205. 20 indexed citations
11.
Han, Hui, et al.. (2019). Mutual regulations and breast cancer cell control by steroidogenic enzymes: Dual sex-hormone receptor modulation upon 17β-HSD7 inhibition. The Journal of Steroid Biochemistry and Molecular Biology. 193. 105411–105411. 4 indexed citations
12.
13.
Chu, Li, Juemin Fang, Chunyan Li, et al.. (2015). The Traditional Chinese Medicinal Formula BDL301 Suppresses Tumor Growth by Inhibiting STAT3 Pathway and Inducing Apoptosis in Colorectal Cancer Cells. DNA and Cell Biology. 34(3). 178–188. 9 indexed citations
14.
Han, Hui, Fangli Cao, Bao‐Zhong Wang, et al.. (2014). Expression of Angiogenesis Regulatory Proteins and Epithelial-Mesenchymal Transition Factors in Platelets of the Breast Cancer Patients. The Scientific World JOURNAL. 2014. 1–7. 14 indexed citations
15.
Cao, Fangli, Wei‐Hong Zhang, Fang Zhang, et al.. (2014). Prognostic significance of high-risk human papillomavirus and p16(INK4A) in patients with esophageal squamous cell carcinoma.. PubMed. 7(10). 3430–8. 23 indexed citations
16.
Han, Hui, et al.. (2013). Clinical curative effect and safety of therapy of supplementing qi and activating blood on acute ischemia stroke(syndrome of qi deficiency and blood stasis): a Meta-analysis. 36(11). 745–751. 1 indexed citations
17.
Zhang, Fang, Hui Han, Chuansheng Wang, et al.. (2013). A retrospective study: the prognostic value of anemia, smoking and drinking in esophageal squamous cell carcinoma with primary radiotherapy. World Journal of Surgical Oncology. 11(1). 249–249. 17 indexed citations
18.
Gong, Lei, et al.. (2011). Reduced survival of patients with hepatocellular carcinoma expressing hexokinase II. Medical Oncology. 29(2). 909–914. 60 indexed citations
19.
Zhou, Fang, et al.. (2007). [Expression and clinical significance of survivin and PTEN in adrenal tumors].. PubMed. 26(10). 1143–7. 3 indexed citations
20.
Hyslop, Terry, et al.. (1997). Performance status and age as independent predictors of survival among AIDS patients with primary CNS lymphoma: a multivariate analysis of a multi-institutional experience.. PubMed. 3(1). 52–6. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yukari Ishiguro Breakdown of academic impact, for papers by Amr S. Saad Breakdown of academic impact, for papers by Leo Y. Luo Breakdown of academic impact, for papers by Yaqi Song Breakdown of academic impact, for papers by Anrong Mao Breakdown of academic impact, for papers by Zhe-Sheng Wen Breakdown of academic impact, for papers by Yuping Zhu Breakdown of academic impact, for papers by Huijuan Feng
Rankless by CCL
2026